Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News £17.9m for Advanced Therapy Treatment Centre network to bolster UK clinical trial infrastructure The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
04 March 2024 New research will target earliest stages of bone marrow cancer The opportunity to eradicate a major and incurable bone marrow cancer has been made possible with a new programme funded by Cancer Research UK.
02 February 2024 New research into autoimmune liver condition suggests unique cell movements may be driving disease A Birmingham study reveals a novel cellular phenomenon could be responsible for the onset of primary biliary cholangitis (PBC).
02 February 2024 Immune cells lose ‘killer instinct’ in cancerous tumours – but functionality can be re-awakened First study tracking how NK cells respond in tumours found that stimulating the IL-15 pathway prevented the rapid loss of function and improved tumour control
30 January 2024 New appointment: Dr Shivan Sivakumar Dr Shivan Sivakumar, a nationally recognised oncologist in cancers of the pancreas, liver and biliary tract, joins the College of Medical and Dental Sciences.
15 December 2023 Research Fellow receives five-year £706K Wellcome Trust Early-Career Award Dr Sally Clayton will study a novel pathway that becomes dysregulated in inflammatory diseases and how it controls the function in immune cells.
12 December 2023 Funding boost supports tackling bacterial infections worldwide through collaborative innovation New funding, announced by the Medical Research Council, will support BactiVac, the Bacterial Vaccines Network as well as other global vaccine research.
07 November 2023 Promising target for liver disease treatments identified Inhibiting a protein involved in liver inflammation has the potential to reduce or stop fibrosis in patients with non-alcoholic steatohepatitis, trial finds